Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Other Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

Insight Molecular Diagnostics Inc. Other Current Liabilities

Insight Molecular Diagnostics Inc. (IMDX) had Other Current Liabilities of $1.98 million as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-10

  • 2026-06-30: Other Liabilities, Current $1.98M.
  • 2026-03-31: Other Liabilities, Current $2.74M.
  • 2025-12-31: Other Liabilities, Current $2.78M.
  • 2024-12-31: Other Liabilities, Current $638.00K.
Period endOther Liabilities, Current
2026-06-30$1.98M
10-Q · filed 2026-08-10
2026-03-31$2.74M
10-Q · filed 2026-05-13
2025-12-31$2.78M
10-Q · filed 2026-08-10
2024-12-31$638.00K
10-K · filed 2026-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92